N. Shepardson, G. Shankar, and D. Selkoe, Cholesterol Level and Statin Use in Alzheimer Disease, Archives of Neurology, vol.68, issue.10, pp.1239-1244, 2011.
DOI : 10.1001/archneurol.2011.203

N. Shepardson, G. Shankar, and D. Selkoe, Cholesterol Level and Statin Use in Alzheimer Disease, Archives of Neurology, vol.68, issue.11, pp.1385-1392, 2011.
DOI : 10.1001/archneurol.2011.242

N. The, Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, Circulation, vol.106, pp.3143-3421, 2002.

A. Sanders, C. Wang, M. Katz, C. Derby, N. Barzilai et al., Association of a Functional Polymorphism in the Cholesteryl Ester Transfer Protein (<emph type="ital">CETP</emph>) Gene With Memory Decline and Incidence of Dementia, JAMA, vol.303, issue.2, pp.150-158, 2010.
DOI : 10.1001/jama.2009.1988

S. Artero, M. Ancelin, F. Portet, A. Dupuy, C. Berr et al., Risk profiles for mild cognitive impairment and progression to dementia are gender specific, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.9, pp.979-984, 2008.
DOI : 10.1136/jnnp.2007.136903
URL : https://hal.archives-ouvertes.fr/inserm-00294905

A. Dupuy, I. Carriere, J. Scali, J. Cristol, K. Ritchie et al., Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents, Climacteric, vol.5, issue.1, pp.74-83, 2008.
DOI : 10.1161/CIRCULATIONAHA.106.642280
URL : https://hal.archives-ouvertes.fr/inserm-00243077

J. Larosa, Lipids and cardiovascular disease: Do the findings and therapy apply equally to men and women?, Women's Health Issues, vol.2, issue.2, pp.102-111, 1992.
DOI : 10.1016/S1049-3867(05)80278-6

M. Mendelsohn and R. Karas, Molecular and Cellular Basis of Cardiovascular Gender Differences, Science, vol.308, issue.5728, pp.1583-1587, 2005.
DOI : 10.1126/science.1112062

3. The and . Group, Vascular factors and risk of dementia: Design of the three city study and baseline characteristics of the study population, 2003.

I. Carriere, A. Fourrier-reglat, J. Dartigues, O. Rouaud, F. Pasquier et al., Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population, Archives of Internal Medicine, vol.169, issue.14, pp.1317-1324, 2009.
DOI : 10.1001/archinternmed.2009.229
URL : https://hal.archives-ouvertes.fr/inserm-00415864

L. Radloff, The CES-D Scale: A Self-Report Depression Scale for Research in the General Population, Applied Psychological Measurement, vol.1, issue.3, pp.385-401, 1977.
DOI : 10.1177/014662167700100306

D. Commenges, L. Letenneur, P. Joly, A. Alioum, and J. Dartigues, Modelling age-specific risk: application to dementia, Statistics in Medicine, vol.17, issue.17, pp.1973-1988, 1998.
DOI : 10.1002/(SICI)1097-0258(19980915)17:17<1973::AID-SIM892>3.0.CO;2-5

H. Jick, G. Zornberg, S. Jick, S. Seshadri, and D. Drachman, Statins and the risk of dementia, The Lancet, vol.356, issue.9242, pp.1627-1631, 2000.
DOI : 10.1016/S0140-6736(00)03155-X

M. Haag, A. Hofman, P. Koudstaal, B. Stricker, and M. Breteler, Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study, Journal of Neurology, Neurosurgery & Psychiatry, vol.80, issue.1, pp.13-17, 2009.
DOI : 10.1136/jnnp.2008.150433

T. Rea, J. Breitner, B. Psaty, A. Fitzpatrick, O. Lopez et al., Statin Use and the Risk of Incident Dementia, Archives of Neurology, vol.62, issue.7, pp.1047-1051, 2005.
DOI : 10.1001/archneur.62.7.1047

P. Zandi, D. Sparks, A. Khachaturian, J. Tschanz, M. Norton et al., Do Statins Reduce Risk of Incident Dementia and Alzheimer Disease?<subtitle>The Cache County Study</subtitle>, Archives of General Psychiatry, vol.62, issue.2, pp.217-224, 2005.
DOI : 10.1001/archpsyc.62.2.217

K. Rockwood, S. Kirkland, D. Hogan, C. Macknight, H. Merry et al., Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly People, Archives of Neurology, vol.59, issue.2, pp.223-227, 2002.
DOI : 10.1001/archneur.59.2.223

D. Bhateja, D. Dhull, A. Gill, A. Sidhu, S. Sharma et al., Peroxisome proliferator-activated receptor-?? activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: Possible neuroprotective mechanisms, European Journal of Pharmacology, vol.674, issue.1, pp.33-43, 2012.
DOI : 10.1016/j.ejphar.2011.10.029